CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV) announced today that its CEO, Martin J. Driscoll, and Stephen J. Tulipano, CFO, will host a conference call to discuss the Company’s quarterly results for the period ending March 31, 2009. The call will be held Thursday, May 7, 2009 at 8:30a.m. EDT.
